Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(132 intermediate revisions by 6 users not shown)
Line 3: Line 3:
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''!!'''Associate Editor'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!Author Content (Pending or Complete)
!'''Date Assigned to Author'''
!Editor Reviewed (Date)
!'''Target Completion Date'''
!Notes
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|Fabiola Quintero-Rivera (FQR)
|
|
|
|
|
|-
|-
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans+Jack Reid+Fabiola Quintero-Rivera
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
| ||FQR
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|
|FQR
|
|
|
|
Line 29: Line 42:
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|Gokce A. Toruner
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 36: Line 52:
|    Primary Myelofibrosis  (PMF)||Disease
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|T. Niroshi  Senaratne
|FQR
|
|
|
|
|complete
|
|FQR
|8/4/2020 before submission
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
| ||FQR
|(trainee), Daynna J.Wolff
|
|
|
|pending faculty review
|
|FQR
|
|
|
|
|-
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Mark Evans+ Fabiola Quintero-Rivera
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|
|complete
| ||FQR
|
|
|
|
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
|Thuy Phung
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|FQR
|FQR
|PENDING
|
|
|
|
Line 75: Line 110:
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|Shashi Shetty
|
|
|complete
|
|FQR
|FQR
|
|
|
|
|
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
|Thuy Phung
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|FQR
|
|
|
|
|complete
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Daynna J.Wolff
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|FQR
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|Complete
|Complete
|
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Daynna J.Wolff
|FQR
|FQR
|PENDING
|
|
|
|
Line 119: Line 175:
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Disease
|Daynna J. Wolff
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
Line 127: Line 186:
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Disease
|Daynna J. Wolff
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|FQR
|
|Complete
|
|Complete
|
|FQR
|
|
|
|
|-
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu+Fabiola Quintero-Rivera
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|FQR
|PENDING
|
|
|
|
|-
|complete
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|
|
|FQR
|
|
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|
|
|complete
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu+Teresa Smolarek
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|FQR
|PENDING
|
|
|9/1/20
|pending
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease||Xiaoli Du+Teresa Smolarek
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu+Teresa Smolarek
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|FQR
|Complete
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu+Teresa Smolarek
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|FQR
|
|9/1/20
|PENDING
|PENDING
|
|
|
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du+Teresa Smolarek
|FQR
|FQR
|PENDING
|
|
|
|
|-
|-
| || || ||
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|
|9/1/20
|PENDING
|
|FQR
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Path Resident
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|Jennelle Hodge (JH)
|Complete
|
|
|
|
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou||JH
|Complete
|Complete
|
|
|
|FQR
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Path Resident||JH
|PENDING
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang||JH
|    Myelodysplastic Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|PENDING
|
|
|
|
|-
|complete
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori||JH
|
|PENDING
|FQR
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang||JH
|    Refractory Cytopenia of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|PENDING
|
|FQR
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou||JH
| || ||
|Complete
|
|
|
|
|
|-
| ||
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+Path Resident||JH
|Complete
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+Path Resident
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|JH
|Complete
|
|
|
|
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke||JH
|Complete
|Complete
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke||JH
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|Complete
|
|
|
|
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty||JH
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty||JH
|Complete
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge||JH
|    Myeloid Neoplasms with Germline DDX41 Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca||JH
|Complete
|Complete
| ||JH / MS
|03/01/2021-MS
|
|
|Need permission for figure?  Update WHO?
|-
|-
|    Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH
|    Myeloid Neoplasms with Germline RUNX1 Mutation||Disease||Malini Sathanoori
|
|
|Complete
|Complete
|02/03/2021||JH / MS
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng  Choy via Greg Conboy (Monash Health)||JH
|    Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease||Fei Yang
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy via Greg Conboy (Monash Health)||JH
|Complete
|Complete
| ||JH / MS
|03/02/2021-MS
|
|
|Add WHO reference
|-
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg  Conboy (Monash Health)||JH
|    Myeloid Neoplasms with Germline ETV6 Mutation||Disease||Ying Zou
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Path Resident  (Iris Martin)||JH
|Complete
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|
|
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang||JH
|Complete
|Complete
|
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + resident||JH
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|PENDING
|
|
|
|
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar  Iqbal||JH
|Complete
|Complete
|
|
|JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera||JH
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
|Complete
|
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease||Jennelle Hodge||JH
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|Complete
|
|
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Maturation||Disease||Jennelle Hodge||JH
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang||JH
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|Complete
|
|
|
|
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang||JH
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra||JH
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|Complete
|
|
|
|
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang||JH
|Complete
|Complete
|
| ||JH / MS
|03/01/2021-MS (re-review)
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra||JH
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|Complete
|
|
|
|
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and  Jialing Huang||JH
|Complete
|Complete
|
| ||JH / MS
|02/24/2021-MS (re-review)
|
|
|-
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera||JH
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|Complete
|
|
|
|
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp||JH
|Complete
|Complete
| ||JH / MS
|
|
|Need permission for figure?
|Need permission for figure?  Update WHO?
|-
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley||JH
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|Complete
|
|
|
|
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley||JH
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Path Resident||JH
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|Complete
|
|
|
|
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge||JH
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + resident||JH
|    Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|PENDING
|
|
|
|Complete
| ||JH / MS
|
|
|Add WHO reference
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker||JH
|    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker||JH
|    Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + resident||JH
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|PENDING
|
|
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera||JH
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not  Otherwise Specified (NOS), Rare Types||Disease|| ||JH
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|??
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|??
|
|
|
|
|-
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng  Choy via Greg Conboy (Monash Health)
|JH
|Complete
|Complete
| ||JH / MS
|
|
|NON-WHO ENTITY
|-
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Path Resident
|JH
|PENDING
|
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6
|    Acute Myeloid Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|Disease
|Daynna Wolff+Path Resident
|JH
|PENDING
|
|
|NON-WHO ENTITY
|-
| || || ||
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|YA
|PENDING
|
|
|
|
|-
|Complete
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
| ||JH / MS
|
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease||Ashwini Yenamandra +
Lisa Smith + Yassmine Akkari
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|YA
|Complete
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease|| ||YA
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|
|
|Complete
| ||JH / MS
|
|
|Need permission for figure?
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|
|
|Complete
| ||JH / MS
|
|
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Helene Bruyere
|YA
|PENDING
|
|
|NON-WHO ENTITY
|-
|-
| || || ||
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|SP
|
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Honey Reddi
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Honey Reddi
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|SP
|
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|SP
|
|
|
|
|Malini to review
|Complete
|-
| ||JH / MS
|Hairy Cell Leukemia||Disease||Snehal Patel
|SP
|
|
|
|
|Malini to review
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|SP
|
|
|
|
|Malini to review
|Complete
|-
| ||JH / MS
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|SP
|
|
|
|
|Malini to review
|-
|-
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|    Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|SP
|
|
|PENDING
| ||JH / MS
|
|
|
|
|Malini to review
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Honey Reddi
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|SP
|
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|   Waldenstrom Macroglobulinemia||Disease||Honey Reddi
|Acute Myeloid Leukemia (AML) with Mutated FLT3
|SP
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
|Complete
|
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|
|
|PENDING
|
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|
|PENDING
|
|
|JH / MS
|
|
|NON-WHO ENTITY
|-
|-
|    Mu Heavy Chain  Disease||Disease|| ||SP
| || ||
|
|
|
|
|
|
|-
| ||
|   Gamma Heavy Chain  Disease||Disease|| ||SP
|
|
|
|
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|-
|    Alpha Heavy Chain  Disease||Disease|| ||SP
|
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|SP
|
|
|
|
|
|-
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|SP
|
|
| ||YA
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|SP
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Plasma Cell Myeloma Variants||Disease||Zhenya Tang
|    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|SP
|
|
|
|
|PENDING
|
|
|-
|YA
|    Plasmacytoma||Disease||Zhenya Tang
|SP
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|           Primary Amyloidosis||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra +
 
Lisa Smith + Yassmine Akkari
|
|
|
|
|Complete
|
|
|-
|YA
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|SP
|
|
|
|
|Complete
|
|
|-
|YA
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
|
|
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease||Holli Drendel
|
|
|-
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease|| ||SP
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease|| ||SP
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Testicular Follicular  Lymphoma||Disease|| ||SP
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|
|YA
|
|NON-WHO ENTITY
|-
|-
|    In Situ Follicular  Neoplasia||Disease|| ||SP
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||SP
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|
|-
|YA
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
|
|
|
|NON-WHO ENTITY
|-
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|SP
|Disease
|Alaa Koleilat
|
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|SP
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|SP
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
| || || ||
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
| || ||
|
|
|
|
|
|
|-
| ||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||Snehal Patel (SP)
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
|
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|
|-
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease|| ||GC
|       Monoclonal B-cell  Lymphocytosis||Disease||
|
|
|
|
|
|
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease|| ||GC
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
|
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC
|Hairy Cell Leukemia||Disease||Snehal Patel
|completed
|
|
|
|
|-
|Complete
|Primary Effusion Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|   Multicentric Castleman  Disease||Disease|| ||GC
|
|
|
|
|
|-
|-
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|    Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
|
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease|| ||GC
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
|-
|SP
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
|
|
|
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|
|-
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
|    High-Grade B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|
|
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
|
|
|SP
|
|
|
|
|-
|-
| || || ||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
|
|
|
|-
| ||SP
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|
|
|
|
|
|-
|-
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
|
|
|-
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP
|
|
| ||SP
|
|
|
|
|-
|-
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP
|    Mu Heavy Chain  Disease||Disease||
|
|
|
|
|
|
|-
| ||SP
|Aggressive NK-cell Leukemia||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''|| ||SP
|   Gamma Heavy Chain Disease||Disease||Manisha Sutariya
|
|
|
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|  Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease|| ||SP
|    Alpha Heavy Chain Disease||Disease||
|
|
|
|
|
|
|-
| ||SP
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease|| ||SP
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|SP
|    Severe Mosquito Bite  Allergy||Disease|| ||SP
|
|
|
|
|
|-
|-
|Adult T-cell Leukemia/Lymphoma||Disease|| ||SP
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|SP
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease|| ||SP
|
|
|
|
|
|-
|-
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''|| ||SP
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|
|
|PENDING
|
|
|-
|SP
|     Enteropathy-Associated T-cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|SP
|
|
|
|
|PENDING
|
|
|-
|SP
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
|
|
|
|
|
|-
|-
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease|| ||SP
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|
|
|PENDING
|
|
|-
|SP
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP
|
|
|
|
|
|-
|-
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease|| ||SP
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||SP
|Mycosis Fungoides||Disease|| ||SP
|
|
|
|
|
|-
|-
|Sézary Syndrome||Disease|| ||SP
|           Primary  Amyloidosis||Disease||
|
|
|
|
|
|
|-
| ||SP
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''|| ||SP
|
|
|
|
|
|-
|-
|    Lymphomatoid Papulosis||Disease|| ||SP
|           Light Chain and Heavy Chain Deposition Disease||Disease||
|
|
|
|
|
|-
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''|| ||SP
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
|
|
|
|-
| ||SP
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease|| ||SP
|
|
|
|
|
|-
|-
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease|| ||SP
|         POEMS Syndrome||Disease||
|
|
|
|
|
|-
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease|| ||SP
|
|
| ||SP
|
|
|
|
|-
|-
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease|| ||SP
|         TEMPI Syndrome||Disease||
|
|
|
|
|
|
|-
| ||SP
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||SP
|
|
|
|
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|
|-
|PENDING
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''|| ||SP
|
|
|SP
|
|
|
|
|-
|-
|     Angioimmunoblastic  T-cell Lymphoma||Disease|| ||SP
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
|    Follicular T-cell Lymphoma||Disease|| ||SP
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|
|Complete
|11/11/2020
|SP
|
|
|
|
|-
|-
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease|| ||SP
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|SP
|SP
|
|
|
|
|
|-
|-
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|SP
|
|
|
|
|PENDING
|
|
|-
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|SP
|SP
|
|
|
|
|
|-
|-
| || || ||
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''|| ||Associate Editor??
|
|
|
|
|
|-
|-
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease|| ||
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|
|
|PENDING
|
|
|-
|SP
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''|| ||
|
|
|
|
|-
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|-
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease|| ||
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease|| ||
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease|| ||
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease|| ||
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|
|8/15/20
|PENDING
|
|SP
|
|
|
|
|-
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease||
|
|
|
|
|
|
|-
|Lymphomas Associated with HIV Infection||Disease|| ||
|
|
|SP
|
|
|
|
|-
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease|| ||
|
|
|SP
|
|
|
|
|-
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||''Anna Shestakova,''
| || ||
 
|
Fabiola Quintero-Rivera
|
|
|
|
| ||
|
|
|
|
|-
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''|| ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|
|
|PENDING
|
|
|-
|Greg Corboy (GC)
|          Monomorphic  B-cell PTLD||Disease|| ||
|
|
|
|
|
|-
|-
|          Monomorphic  T/NK-cell PTLD||Disease|| ||
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease|| ||
|
|
|
|
|
|-
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease|| ||
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
|
|
|
|-
| ||GC
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''|| ||
|
|
|
|
|
|-
|-
|Histiocytic Sarcoma||Disease|| ||
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
|
|
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''|| ||
|
|
| ||GC
|
|
|
|
|-
|-
|   Langerhans Cell Histiocytosis||Disease|| ||
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
|-
| ||GC
|   Langerhans Cell  Sarcoma||Disease|| ||
|
|
|
|
|
|-
|-
|Indeterminate Dendritic Cell Tumour||Disease|| ||
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease|| ||
|
|
| ||GC
|
|
|
|
|-
|-
|Follicular Dendritic Cell Sarcoma||Disease|| ||
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease|| ||
|
|
| ||GC
|
|
|
|
|-
|-
|Fibroblastic Reticular Cell Tumor||Disease|| ||
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
|Disseminated Juvenile Xanthogranuloma||Disease|| ||
|
|
|
|
|
|-
|-
|Erdheim-Chester Disease||Disease|| ||
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|-
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|-
| || || ||
|
|
|Complete
| ||GC
|
|
|
|
|-
|-
| || || ||
|Primary Effusion Lymphoma||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|   Multicentric Castleman  Disease||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|-
|-
| || || ||
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|-
| || || ||
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|
|PENDING
| ||GC
|
|
|
|
|-
|-
| || || ||
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
|
|
|
|-
| ||GC
| || || ||
|
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Associate Editor'''
!Author Content
(Pending or Complete)
!Editor Reviewed (Date)
!Notes
|-
|-
|BCR
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|ABL1
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RUNX1
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|RUNX1T1
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|MYH11
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|FLT3
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|NPM1
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|TP53
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|DNMT3A
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|CEBPA
|Aggressive NK-cell Leukemia||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|IDH1
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|IDH2
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|PML
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|RARA
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|ETV6
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|KIT
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|CBFB
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|GATA2
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|PTEN
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|MLTT3
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|MECOM
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|FGFR1(FLT2)
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|KMT2A
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|DEK
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|NUP214
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|RBM15
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|MKL1
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|DDX41
|    Lymphomatoid  Papulosis||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|ANKRD26
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|CUX1
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|TET2
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|EZH2
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|FOXP1
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|MYC
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|JAK2
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|WT1
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||SP
|
|
|
|
|-
|-
|CBL
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|NF1
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|SUZ12
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|ERG
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|EST2
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|RPS14
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|
|
|PENDING
|
|
|SP
|
|
|
|
|-
|-
|RB1
| || ||
|
|
|
|
|
|
| ||
|
|
|
|
|-
|-
|MPL
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|CHGA
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|CDH1
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
|
|
|
| ||GC
|
|
|
|
|-
|-
|SRSF2
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|PENDING
|
|GC
|
|
|-
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|-
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|-
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|Histiocytic Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
| ||GC
|
|
|-
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|-
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
| || ||
|
|
|
| ||
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|-
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|-
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|-
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|-
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|-
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|-
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|-
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|-
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|-
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|-
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|-
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|-
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|-
|MLTT3
|
|
|
|
|
|
|
|
|-
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|-
|KMT2A
|
|
|
|
|
|
|
|
|-
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|-
|RBM15
|
|
|
|
|
|
|
|
|-
|MKL1
|
|
|
|
|
|
|
|
|-
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|-
|ANKRD26
|
|
|
|
|
|
|
|
|-
|CUX1
|
|
|
|
|
|
|
|
|-
|TET2
|
|
|
|
|
|
|
|
|-
|EZH2
|
|
|
|
|
|
|
|
|-
|FOXP1
|
|
|
|
|
|
|
|
|-
|MYC
|
|
|
|
|
|
|
|
|-
|JAK2
|
|
|
|
|
|
|
|
|-
|WT1
|DONE
|
|
|DONE
|
|
|
|
|-
|CBL
|
|
|
|
|
|
|
|
|-
|NF1
|
|
|
|
|
|
|
|
|-
|SUZ12
|
|
|
|
|
|
|
|
|-
|ERG
|
|
|
|
|
|
|
|
|-
|EST2
|
|
|
|
|
|
|
|
|-
|RPS14
|
|
|
|
|
|
|
|
|-
|RB1
|
|
|
|
|
|
|
|
|-
|MPL
|
|
|
|
|
|
|
|
|-
|CHGA
|
|
|
|
|
|
|
|
|-
|CDH1
|
|
|
|
|
|
|
|
|-
|SRSF2
|
|
|
|
|
|
|
Line 1,709: Line 2,690:
|
|
|
|
|
|
|-
|PRDX2
|
|
|
|
Line 1,719: Line 2,696:
|
|
|-
|-
|ASXL1
|PRDX2
|
|
|
|
|
|
|
|
|
|-
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|-
|MN1
|
|
|
|
|
|
|
|
|-
|SF3A1
|
|
|
|
|
|
|
|
|-
|EP300
|
|
|
|
|
|
|
|
|-
|JARID2
|
|
|
|
|
|
|
|
|-
|BRCA1
|
|
|
|
|
|
|
|-
|MN1
|
|
|
|
Line 1,733: Line 2,766:
|
|
|-
|-
|SF3A1
|BRCA2
|
|
|
|
|
|
|
|
|-
|EP300
|
|
|
|
Line 1,747: Line 2,776:
|
|
|-
|-
|JARID2
|
|
|
|
|
|
|
|
|-
|
|
|
|
|
|
|-
|
|
|
|
Line 1,771: Line 2,789:
|
|
|
|
|
|
|
|-
|
|
|
|
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"